|
Title |
|
|
|
Phase I/II study of refametinib (BAY 86-9766) in combination with gemcitabine in advanced pancreatic cancer
| |
Author |
|
|
|
| |
Abstract |
|
|
| | |
Language |
|
|
|
English
| |
Source (journal) |
|
|
|
Targeted oncology. - Paris | |
Publication |
|
|
|
Paris : 2017
| |
ISSN |
|
|
|
1776-2596
| |
Volume/pages |
|
|
|
12:1(2017), p. 97-109
| |
ISI |
|
|
|
000393121700010
| |
Full text (Publisher's DOI) |
|
|
| | |
Full text (publisher's version - intranet only) |
|
|
| | |
|
Faculty/Department |
|
|
| | |
Research group |
|
|
| | |
Subject |
|
|
| | |
Affiliation |
|
|
|
Publications with a UAntwerp address
| |
|
|
Identification |
|
| |
|
|
Creation |
|
| |
02.08.2018
|
|
Last edited |
|
| |
03.03.2021
|
|
To cite this reference |
|
|
| | |
|
| |